| Predicate |
Object |
| contentType |
Clinical Trial, Phase I|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't |
| endingPage |
11 |
| issn |
1532-1827
0007-0920 |
| issueIdentifier |
1 |
| pageRange |
7-11 |
| publicationName |
British Journal of Cancer |
| startingPage |
7 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_edd39452353bcea0edc05941b3ce5978
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_848a19ea599a0132f778b81b991c470d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2445cf923ffa1963ba81461fa68a69b1
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d96019d367d9735e29b377f48495836b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_146da4bafb52d930fd526b5d7d712e41 |
| bibliographicCitation |
Aft RL, Naughton M, Trinkaus K, Weilbaecher K. Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer. British Journal of Cancer. 2012 May 22;107(1):7–11. doi: 10.1038/bjc.2012.210. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77d5cd4d7728772fbf50e215a56a0d62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b82cfb435f0dbae3dccbbb7caaeb96fd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_872ceb377dabd274475bfe5dfd079320
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d05d9e0a081683e3a728c41f5cbc8a9 |
| date |
2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3389411
https://doi.org/10.1038/bjc.2012.210
https://pubmed.ncbi.nlm.nih.gov/22617128 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer |
| discusses |
http://id.nlm.nih.gov/mesh/M0006519
http://id.nlm.nih.gov/mesh/M0472480
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0018586
http://id.nlm.nih.gov/mesh/M0234600 |
| hasSubjectTerm |
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |